Edesa Biotech, Inc. SBOT Income Statement

Edesa biotech, inc. (SBOT)

Income statement / Quarterly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Aug'14	Jun'14	Mar'14	Dec'13
Revenues:
Revenue from Contract with Customer
-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Product sales
-	-	-	-	-	-	-	-	-	-	-	-	13	141	276	181	326	456	155	112	142	152	72	12	42	16
Contract services revenue
-	-	-	-	-	-	-	-	-	-	-	-	50	-	0	0	0	32	45	45	45	60	45	60	72	15
Grant revenue
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	8	0	0	27
Product sales and services
110	107	410	0	0	0	127	0	64	20	2	20	63	141	276	181	326	488	200	157	187	212	126	72	114	58
Product sales and services
110	107	410	0	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Expenses:
Cost of sales
10	3	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Costs of contract services
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	41	27	10
Cost of sales
-	-	-	-	-	-	-	-	-	-	-	-	-	78	-	-	-	-	-	-	-	-	-	147	147	146
Cost of sales
-	-	-	-	-	-	19	45	65	2	-	77	71	-	117	119	268	312	9	231	243	95	-	-	-	-
Costs of aquaculture
-	-	-	-	-	-	70	69	74	98	71	64	63	84	86	59	79	84	57	53	66	81	-	-	-	-
Grant costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	8	0	0	27
Research and development
502	527	481	502	111	257	664	298	493	631	646	536	329	460	661	470	309	288	199	129	281	418	634	543	733	548
General and administrative
1,113	681	798	817	429	148	1,181	123	773	678	630	635	746	932	727	720	765	1,109	881	618	785	942	591	612	646	1,021
Total expenses
1,626	1,213	1,381	1,320	540	405	-616	421	1,407	1,410	1,371	1,314	1,210	1,556	1,592	1,369	1,422	1,795	1,148	1,033	1,377	1,538	1,436	1,344	1,555	1,754
Loss from operations
-1,516	-1,105	-971	-1,320	-540	-405	-1,922	-421	-1,343	-1,389	-1,368	-1,293	-1,147	-1,414	-1,316	-1,188	-1,095	-1,307	-	-	-	-	-	-	-	-
Other income (loss):
Gain (loss) in fair value of warrant liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-211	-324	1,254	1,061	139	-3,367	4,528	185	-3,880
Interest income
18	14	25	15	15	16	43	16	7	7	7	9	8	6	8	2	8	5	6	17	18	13	16	14	14	15
Foreign exchange gain (loss)
7	-2	-6	8	-3	24	5	-6	-16	-17	140	64	35	-77	-32	-8	226	-109	-262	77	-307	-161	-169	146	-182	-16
Gain on disposition of property and equipment
-	-	-	2	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total other income (loss)
26	12	17	26	11	40	39	10	-8	-10	147	73	43	-70	-24	-5	234	-315	-580	1,348	772	-8	-3,520	4,689	18	-3,880
Loss before income taxes
-1,489	-1,093	-	-	-528	-364	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss Before Income Tax
-	-	-	-	-	-	-1,129	-1,156	-1,352	-1,399	-1,220	-1,220	-1,103	-1,484	-1,341	-1,194	-861	-1,622	-1,528	472	-417	-1,333	-4,830	3,417	-1,422	-5,576
Income tax expense
0	0	-	-	0	0	0	0	0	0	0	0	0	0	0	0	0	7	9	9	9	9	6	9	11	0
Net loss
-1,489	-1,094	-953	-1,294	-528	-364	592	-411	-1,352	-1,400	-1,220	-1,220	-1,103	-1,485	-1,341	-1,194	-861	-1,629	-1,537	463	-426	-1,343	-4,836	3,408	-1,433	-5,577
Exchange differences on translation
-39	18	-12	27	73	17	-	19	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net loss and comprehensive loss
-1,529	-1,076	-966	-1,266	-455	-347	-	-392	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Loss and Comprehensive Loss
-	-1,076	-	-	-	-347	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Basic
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.06	-	-	-1.05	0.04	-0.02	-0.08
Diluted
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.05	-	-	-1.05	0.04	-0.02	-0.08
Weighted average number of common shares
8,740	7,504	7,551	4,317	3,239	3,239	4,976	3,239	1,502	1,502	-7,184	1,450	1,448	10,136	-20,227	8,448	8,448	8,373	-	-	7,954	7,946	-	-	-	-
Loss per share - basic and diluted
-0.17	-0.15	-0.09	-0.30	-0.16	-0.11	0.67	-0.13	-0.90	-0.93	-1.69	-0.84	-0.76	-0.15	-3.56	-0.14	-0.10	-0.19	-	-	-0.05	-0.17	-	-	-	-
Basic (in shares)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	7,954	-	-	-196,122	76,237	76,237	73,978
Diluted (in shares)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	8,502	-	-	-206,784	86,898	76,237	73,978
Product [Member]
Revenue from Contract with Customer
-	-	-	-	-	-	-	-	64	20	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-